Aslı İmran Yılmaz

Bronkopulmoner Displazi Tanısı, Yönetimi ve Koruyucu Aşılamalar

Aslı İmran Yılmaz

Bronkopulmoner displazi (BPD), prematüre bebeklerde görülen kronik bir akciğer hastalığıdır ve özellikle çok düşük gestasyon haftasında doğan bebeklerde önemli morbidite ve mortalite nedenlerinden biridir. Hastalık, akciğer gelişiminin bozulması ve prematüre akciğerin ventilasyon, oksijen toksisitesi ve enfeksiyon gibi etkenlerle hasar görmesi sonucu ortaya …

A child with interstitial lung disease and hepatic cirrhosis

Aslı İmran Yılmaz, Betül Okur Altındaş, Sevgi Pekcan, Ayşe Gül Zamani et autres

A child with interstitial lung disease and hepatic cirrhosis due to ZNFX1 gene deficiency is presented.

Long‐Term Effect Of COVID‐19 on Children's Lung Function: A Prospective Longitudinal Study

Şule Selin Akyan Soydaş, Ece Ocak, Murat Yasin Gençoğlu, Salih Uytun et autres

ABSTRACT Introduction‐Aim The study evaluates the long‐term effect of COVID‐19 on lung function in children, considering symptoms, physical examination findings, radiologic and laboratory evaluations during the acute infection period (AIP). Material and Methods This prospective, longitudinal, multicenter study involved 270 patients with …

tr (code pays fourni par la source)

Clinical, radiological, and spirometric outcomes of pediatric bronchiolitis obliterans: A ten-year single-center experience

Aslı İmran Yılmaz, Fatih Ercan, Suat Savaş, Necdet Poyraz et autres

Bronchiolitis obliterans (BO) is a chronic and irreversible obstructive lung disease in children. Due to nonspecific clinical manifestations and limited disease-modifying treatment options, BO remains a diagnostic and therapeutic challenge, and data describing long-term clinical, radiological, and functional outcomes are limited. This …

tr (code pays fourni par la source)

Lung function outcomes of cystic fibrosis patients after early‐life pulmonary exacerbations: National registry analysis

Satı Özkan Tabakçı, Salih Uytun, Sanem Eryılmaz Polat, Uz.Dr. Güzin Cinel et autres

BACKGROUND: Pulmonary exacerbations (PEs) are associated with a subsequent decline in lung function. We aim to evaluate lung function in cystic fibrosis (CF) patients with frequent PEs in their first 2 years of age using spirometry at age 6. METHODS: This retrospective …

tr (code pays fourni par la source)

One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?

S Uytun, Şehrinaz Polat, S Özkan Tabakçı, G Cinel et autres

Objectives: It is shown that modulatory therapies(MT) in cystic fibrosis(CF) positively affect pulmonary function tests(PFT) parameters,patients’ weight gain, decreasing lung infections and lung-related deaths and improving quality of life. Many CF patients cannot reach MT in our country. This study aims to …

tr (code pays fourni par la source)

Evaluation of factors affecting bone mineral density in CF patients through CF registry of Turkey

S S Akyan Soydaş, G.D. Tuğcu, M.Y. Gençoğlu, G Cinel et autres

Introduction or Background: With the prolongation of life expectancy in cystic fibrosis(CF),the incidence of late complications,including bone disease,increases. Early diagnosis and treatment of the bone disease will prevent the development of complications. Aims and Objectives: To determine the prevalence of bone disease …

tr (code pays fourni par la source)

The efficacy of inhaled hypertonic saline in children with cystic fibrosis who receive daily DNase.

M Y Gencoglu, G.D. Tuğcu, Ş S Akyan Soydaş, G Cinel et autres

Obective: Hypertonic saline(HS) and recombinant human deoxyribonuclease(rhDNase) are used to force airway clearance in cystic fibrosis(CF) patients. We aimed to evaluate the efficacy of ihaled HS therapy in CFpatients receiving daily rhDNase. Method: A retrospective case-control study was conducted by using the …

tr (code pays fourni par la source)

P024 Pili annulati: is it a new finding in cystic fibrosis?

Mohammad Saaid Daye, Sevgi Pekcan, Melih Hangül, Mina Gharibzadeh Hızal et autres